Therefore, in terms of whether tumor-specific TCRs could be enriched by tumor organoids-autologous TILs immune co-cultures, we found that the proportion of CD137-positive T cells after tumor organoids co-cultures was significantly higher than the control group. This evidence concerns the gene TNFRSF9 and neoplasm.